Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08-02 study.
Auteurs : Gendarme, S ; Zebachi, S ; Corre, R ; Greillier, L ; Justeau, G ; Bylicki, O & al (Guisier F).
